Cardurion Pharmaceuticals (Series B)

Funding Details
Awarder
Inbox
Date Award
July 16, 2024
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$260,000,000

Company Info
Company Description
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Market
Cardiovascular diseases
Location
Burlington, MA, USA
Coinvestors
Ascenta Capital, Bain Capital Life Sciences, Blue Owl, Delos Capital, Digitalis Ventures, Farallon Capital Management, Fidelity Management & Research Company, GV, Invus Capital, Millennium Management, NEA Ventures

Links